Supreme Court Limits Patent Infringement Liability for “Skinny Label” Generic Drugs · Electoral Command Center

On June 4, 2026, the Supreme Court issued its decision in Hikma Pharmaceuticals USA Inc. v. Amarin Pharma, Inc., a closely watched patent-infringement case with significant conseq…